Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | TPMT | P51580 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | TTR | P02766 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | PARG | Q86W56 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | GLRA3 | O75311 | 1/20 | 0.38 |
| ▸ | GLRB | P48167 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | DPP4 | P27487 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29386792 | 1.00 | MAPK1 (0.47) | MAPK1TSHRTPMTTDP1TTR | |
| SCHEMBL377395 | 0.85 | MAPK1 (0.53) | MAPK1TSHRTPMTTDP1LMNA | |
| Hydrochloric Acid SCHEMBL11407766 | 0.83 | MAPK1 (0.52) | MAPK1TSHRTPMTTDP1ALDH1A1 | |
| SCHEMBL23600928 | 0.82 | TPMT (0.48) | MAPK1TSHRTPMTTDP1TTR | |
| SCHEMBL21783790 | 0.82 | TPMT (0.48) | MAPK1TSHRTPMTTDP1TTR | |
| SCHEMBL4277000 | 0.81 | TPMT (0.52) | MAPK1TSHRTPMTTDP1ALDH1A1 | |
| SCHEMBL31409214 | 0.81 | TPMT (0.52) | MAPK1TSHRTPMTTDP1ALDH1A1 | |
| SCHEMBL31518592 | 0.80 | TSHR (0.39) | MAPK1TSHRTPMTTDP1TTR | |
| SCHEMBL22991367 | 0.80 | TTR (0.42) | MAPK1TSHRTDP1TTRLMNA | |
| SCHEMBL10495744 | 0.80 | TSHR (0.39) | MAPK1TSHRTPMTTDP1TTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 554 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114008013-B | Treatment of CNS disorders with sleep disorders | 哥本哈根大学 | 2026-05-15 | — | — | CN | claimed |
| US-20250296959-A1 | B7-H3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | MARIANA ONCOLOGY INC (US) | 2025-09-25 | — | — | US | claimed |
| CN-118731332-A | Kidney-power triple detection test card and corresponding calibration method and system | 江苏康尚医学科技有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-115896236-A | Detection kit and detection method for alanine aminotransferase | 北京安图生物工程有限公司 | 2023-04-04 | — | — | CN | claimed |
| CN-114480565-A | Stable high-sensitivity glycated albumin determination kit with strong anti-interference capability | 桂林优利特医疗电子有限公司 | 2022-05-13 | — | — | CN | claimed |
| CN-114134201-A | Production process of 1, 5-dehydration-D-sorbitol detection reagent by adopting enzyme method | 苏州普瑞斯生物科技有限公司 | 2022-03-04 | — | — | CN | claimed |
| CN-114057600-A | X-ray developable molecule, drug-loaded embolism microsphere and preparation method thereof | 上海汇禾医疗科技有限公司 | 2022-02-18 | — | — | CN | claimed |
| US-20210069352-A1 | IODINE-BASED PARTICLES | NANOPROBES, INC. | 2021-03-11 | — | — | US | claimed |
| CN-109212238-B | Glycated albumin assay kit | 山东博科生物产业有限公司 | 2020-04-28 | — | — | CN | claimed |
| CN-110846378-A | 1, 5-sorbitan detection kit and preparation method thereof | 苏州普瑞斯生物科技有限公司 | 2020-02-28 | — | — | CN | claimed |
| US-6537823-B1 | Use in determination of adulterants in illicit drug screening samples as a means of detecting false negative results | SCITECK DIAGNOSTICS, INC. | 2003-03-25 | — | — | US | claimed |
| US-20030045003-A1 | Method for detection of the adulterant urine luckTM in urine using liquid chemistry, dry chemistry test pads, and lateral flow | SMITH JACK V (US) | 2003-03-06 | — | — | US | claimed |
| US-20030027350-A1 | Method for detection of bromine in urine using liquid chemistry, dry chemistry test pads, and lateral flow | SMITH JACK V (US) | 2003-02-06 | — | — | US | claimed |
| EP-0378395-B1 | Method of measuring cholesterol, diagnosing vascular disease, and raising HDL cholesterol levels | MAINES ROBERT Q (US) | 1996-08-14 | — | — | EP | claimed |
| US-5094943-A | Superoxide dimutase | BOEHRINGER MANNHEIM GMBH (DE) | 1992-03-10 | — | — | US | claimed |
| EP-0378395-A2 | Method of measuring cholesterol, diagnosing vascular disease, and raising HDL cholesterol levels | Maines, Robert Q. (US) | 1990-07-18 | — | — | EP | claimed |
| EP-0186134-B1 | MEANS FOR IMPROVING THE DETERMINATION OF OXIDASE REACTIONS PRODUCING HYDROGEN PEROXYDE, AND THEIR USE | Roche Diagnostics GmbH (DE) | 1989-02-15 | — | — | EP | claimed |
| EP-0101799-B1 | HIGH GLUCOSE-DETERMINING ANALYTICAL ELEMENT | MILES LABORATORIES, INC. (US) | 1985-12-04 | — | — | EP | claimed |
| EP-0101799-A1 | High glucose-determining analytical element | MILES LABORATORIES, INC. (US) | 1984-03-07 | — | — | EP | claimed |
| US-4427770-A | BLOOD GLUCOSE | MILES LABORATORIES, INC. (US) | 1984-01-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296959-A1 | B7-H3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | CD274, CD44, CD74 | MAPK1 2951/4885TSHR 1900/4885TPMT 4383/4885 |
| US-20210069352-A1 | IODINE-BASED PARTICLES | TPO, BRI3BP, INSRR | MAPK1 3330/4885TSHR 25/4885TPMT 4656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.